| Dr Keith D Willner, MD | |
|
1000 E Mountain Blvd, Wilkes Barre, PA 18711 | |
| (570) 808-7762 | |
| Not Available |
| Full Name | Dr Keith D Willner |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 1000 E Mountain Blvd, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386026219 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MT208606 (Pennsylvania) | Secondary |
| 207P00000X | Emergency Medicine | MD462670 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
By combining two imaging modalities-adaptive optics and angiography-investigators at the National Eye Institute can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina.
While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, "men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs," Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding "Targeting men in prevention and treatment ... may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa."
› Verified 5 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
By combining two imaging modalities-adaptive optics and angiography-investigators at the National Eye Institute can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina.
While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, "men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs," Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding "Targeting men in prevention and treatment ... may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa."
› Verified 5 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
By combining two imaging modalities-adaptive optics and angiography-investigators at the National Eye Institute can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina.
While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, "men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs," Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding "Targeting men in prevention and treatment ... may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa."
› Verified 5 days ago
| Entity Name | Fayette Physician Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992107817 PECOS PAC ID: 3375865819 Enrollment ID: O20141211000851 |
News Archive
A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
By combining two imaging modalities-adaptive optics and angiography-investigators at the National Eye Institute can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina.
While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, "men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs," Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding "Targeting men in prevention and treatment ... may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keith D Willner, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Keith D Willner, MD 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Ph: (570) 808-7762 |
News Archive
A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
By combining two imaging modalities-adaptive optics and angiography-investigators at the National Eye Institute can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina.
While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, "men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs," Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding "Targeting men in prevention and treatment ... may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa."
› Verified 5 days ago
Dr. Anthony Ascione, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 575 N River St, Wilkes Barre, PA 18764 Phone: 570-829-8111 | |
Gary Bonfante, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7762 Fax: 570-808-6128 | |
Dr. Lino A. Quilo, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 Church St, Wilkes Barre, PA 18765 Phone: 570-826-3100 | |
Todd C Daniello, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7762 | |
Dr. Patricia M. Ihnat-shroff, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 575 North River Street, Wilkes Barre, PA 18765 Phone: 570-826-3100 | |
Dr. Jeffrey Brian Adler, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 E Mountain Dr, Wilkes Barre, PA 18711 Phone: 570-808-7762 Fax: 570-808-6128 | |
Dan Alan Loughran, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Dr, Wilkes Barre, PA 18711 Phone: 570-808-7762 |